StonvexLoading…
StonvexStonvexStonvexCore line items from SVCO's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $17.75M | $63.06M | $44.81M | $26.14M |
Operating Income | $-5.66M | $-45.90M | $-39.12M | $-29.77M |
Net Income | $-5.86M | $-41.21M | $-33.98M | $-28.68M |
EPS (Diluted) | $-0.19 | $-1.39 | $-1.16 | $-0.99 |
Total Assets | $111.45M | $122.64M | $130.59M | $127.63M |
Total Liabilities | $34.74M | $47.65M | $51.49M | $48.04M |
Cash & Equivalents | $10.93M | $9.01M | $11.95M | $13.13M |
Free Cash Flow OCF − CapEx | $-11.02M | $-34.52M | $-25.01M | $-16.84M |
Shares Outstanding | 32.23M | 30.95M | 30.53M | 29.60M |